Latest Personalized medicine Stories
The Institute for Quantitative and Computational Biosciences will employ multidisciplinary research to study how molecules and genes interact. Its goal: unlocking the biological basis of health and disease by tapping the power of big data and computational modeling.
Co-Founder of numerous life science organizations, Terry to lead commercial growth of Claritas's pediatric genetic testing services CAMBRIDGE, Mass., Dec.
FT. MYERS, Fla., Dec. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc.
LONDON, Dec. 15, 2014 /PRNewswire/ -- The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019.
Positive Results of Largest Genomic Study in DCIS Reconfirm Oncotype DX is a Strong, Independent Predictor of Local Recurrence SAN ANTONIO, Dec.
2013 Nobel Laureate Michael Levitt is Insilico Medicine's latest Scientific Advisory Board addition in the pursuit of working interventions towards aging and aging-related disease.
DALLAS, December 4, 2014 /PRNewswire/ -- ReportsnReports.com adds The Human Microbiome: Biomedical Implications and Birth of a Market 2014 research report of 94 pages to
Personalized, comprehensive health management platform will be rolled out to LABCO’s extensive global patient base, starting in Spain Redwood City, CA (PRWEB)
- A hairdresser.